Interferon alpha-2: Clinical Trials

2 trials of Interferon alpha-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Interferon alpha-2: new trials by email Literature Review of Interferon alpha-2 trials Research Report on Interferon alpha-2

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Methotrexate, Interferon Alfa-2b - Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides
Phase 4TerminatedPolish Lymphoma Research Group1002014-06-012022-01-13
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
PEG-interferon alfa-2b, Interferon alfa-2b, Valproic Acid - Lymphoma, Precancerous/Nonmalignant Condition
Phase 4TerminatedUniversity of Miami132007-11-012018-04-17

Conditions studied

HTLV-I Infections (1)  ·  Lymphoma (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)  ·  Precancerous Conditions (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Polish Lymphoma Research Group (1)  ·  University of Miami (1)

Countries

Poland (1)  ·  United States (1)

Top investigators

Ewa Chmielowska, MD, PhD (1)  ·  Juan Carlos Ramos, MD (1)

Results publications

PMID 32632956

NIH funding

P01CA128115 (1)